Medicare contract · plan years 2026 and 2027CMS landscape and crosswalk
UnitedHealthcare of the Mid-Atlantic, Inc. (H7464)
H7464Contract
A company of UnitedHealth Group, Inc., sold as UnitedHealthcare
3 plans in 2027 (3 in 2026) · 16,903 members in September 2026
UnitedHealthcare of the Mid-Atlantic, Inc. is the UnitedHealth Group, Inc. company that holds Medicare contract H7464, sold as UnitedHealthcare. In 2027 it offers 3 plans (3 in 2026); every one of its 2026 plans continues in 2027. 16,903 people were in its plans in September 2026.
What plans does H7464 offer for 2027?
| Plan | Type | Monthly premium | Out-of-pocket limit | Area | For 2027 |
|---|---|---|---|---|---|
| UHC Dual Complete MD-S002H7464-008 | HMO D-SNP | $0 | $9,850 | 21 counties | renews |
| UHC Dual Choice DC-YL1H7464-010 | HMO D-SNP | $0 | $9,850 | 1 county | renews |
| UHC Dual Complete MD-Q001H7464-012 | HMO D-SNP | $0 | $9,850 | 5 counties | renews |
Source: CMS Medicare Advantage and Part D landscape files for 2027 (Sept. 22, 2026, revised Sept. 30) and 2026 (Sept. 2, 2026 revision); CMS plan crosswalk from 2026 to 2027 (Oct. 1, 2026).
How did CMS rate it for 2026?
The overall rating is 3.5 of 5 (health plan 3.5 of 5, drug plan 3.5 of 5). Of its 42 rated measures, the lowest and the highest:
| Lowest-rated measures | Stars |
|---|---|
| Transitions of Care | 1 |
| Annual Flu Vaccine | 2 |
| Plan All-Cause Readmissions | 2 |
| Getting Needed Care | 2 |
| Highest-rated measures | Stars |
|---|---|
| Medication Adherence for Hypertension (RAS antagonists) | 5 |
| Getting Needed Prescription Drugs | 5 |
| Members Choosing to Leave the Plan | 5 |
| Complaints about the Drug Plan | 5 |
Source: CMS Part C and D Star Ratings data tables, 2026 (October 2025).
What else should you check?
- All UnitedHealthcare plansEvery contract of the brand
- Star ratings of every contractThe 2026 ratings, and 2027 when CMS publishes them
- Find a plan by its IDFrom the card or a letter